These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 30171687)

  • 21. Pemphigus vegetans Neumann type with anti-desmoglein and anti-periplakin autoantibodies.
    Cozzani E; Christana K; Mastrogiacomo A; Rampini P; Drosera M; Casu M; Murialdo G; Parodi A
    Eur J Dermatol; 2007; 17(6):530-3. PubMed ID: 17951135
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pemphigus foliaceus evolving into pemphigus vulgaris: a probable example of 'intermolecular epitope spreading' confirmed by enzyme-linked immunosorbent assay study.
    Pigozzi B; Peserico A; Schiesari L; Alaibac M
    J Eur Acad Dermatol Venereol; 2008 Feb; 22(2):242-4. PubMed ID: 18211424
    [No Abstract]   [Full Text] [Related]  

  • 23. A prospective analysis of anti-desmoglein antibody profiles in patients with rheumatoid arthritis treated with thiol compounds.
    Yamamoto T; Takata-Michigami M; Hisamatsu Y; Yamamoto T; Hamada T; Fujii K; Fujimoto W; Taneichi K; Aoyama Y; Iwatsuki K
    J Dermatol Sci; 2010 Sep; 59(3):170-5. PubMed ID: 20650613
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Possible effect of interleukin-17 blockade in pemphigus foliaceus and neutrophilic diseases].
    Kohlmann J; Simon JC; Kunz M; Treudler R
    Hautarzt; 2019 Aug; 70(8):641-644. PubMed ID: 31076811
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The mapping of linear B-cell epitope regions in the extracellular parts of the desmoglein 1 and 3 proteins: recognition of immobilized peptides by pemphigus patients' serum autoantibodies.
    Szabados H; Bősze S; Silló P; Kárpáti S; Hudecz F; Uray K
    J Pept Sci; 2013 Feb; 19(2):84-94. PubMed ID: 23297065
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Herpetiform pemphigus without anti-desmoglein 1/3 autoantibodies.
    Nakashima H; Fujimoto M; Watanabe R; Ishiura N; Yamamoto AI; Hashimoto T; Tamaki K
    J Dermatol; 2010 Mar; 37(3):264-8. PubMed ID: 20507392
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Anti-desmoglein 1 and 3 antibody, anti-BP180(NC16a) antibody, anti-BP230 antibody].
    Amagai M
    Nihon Rinsho; 2010 Jun; 68 Suppl 6():614-7. PubMed ID: 20942145
    [No Abstract]   [Full Text] [Related]  

  • 28. Delayed immunologic evidence in pemphigus vulgaris.
    Mignogna MD; Fortuna G; Leuci S; Adamo D; Ruoppo E
    J Eur Acad Dermatol Venereol; 2009 Sep; 23(9):1092-3. PubMed ID: 19207659
    [No Abstract]   [Full Text] [Related]  

  • 29. Anti-skin specific autoantibodies detected by a new immunofluorescence multiplex biochip method in patients with autoimmune bullous diseases.
    Tampoia M; Zucano A; Villalta D; Antico A; Bizzaro N
    Dermatology; 2012; 225(1):37-44. PubMed ID: 22907099
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluating efficacy of plasmapheresis for patients with pemphigus using desmoglein enzyme-linked immunosorbent assay.
    Nagasaka T; Fujii Y; Ishida A; Handa M; Tanikawa A; Amagai M; Nishikawa T
    Br J Dermatol; 2008 Apr; 158(4):685-90. PubMed ID: 18241273
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel ELISA systems for antibodies to desmoglein 1 and 3: correlation of disease activity with serum autoantibody levels in individual pemphigus patients.
    Schmidt E; Dähnrich C; Rosemann A; Probst C; Komorowski L; Saschenbrecker S; Schlumberger W; Stöcker W; Hashimoto T; Bröcker EB; Recke A; Rose C; Zillikens D
    Exp Dermatol; 2010 May; 19(5):458-63. PubMed ID: 20163452
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cutaneous pemphigus vulgaris with absence of desmoglein 1 autoantibodies. An example of the extended desmoglein compensation theory.
    Carew B; Wagner G
    Australas J Dermatol; 2014 Nov; 55(4):292-5. PubMed ID: 25399788
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of pemphigus desmoglein 1 and desmoglein 3 autoantibodies and pemphigoid BP180 autoantibodies in saliva and comparison with serum values.
    Andreadis D; Lorenzini G; Drakoulakos D; Belazi M; Mihailidou E; Velkos G; Mourellou-Tsatsou O; Antoniades D
    Eur J Oral Sci; 2006 Oct; 114(5):374-80. PubMed ID: 17026501
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enzyme-linked immunosorbent assay in autoimmune blistering diseases: preliminary experience of the Dermatology Department of Cagliari.
    Atzori L; Deidda S; Aste N
    G Ital Dermatol Venereol; 2008 Feb; 143(1):1-8. PubMed ID: 18833046
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paraneoplastic pemphigus presenting as erythrodermic lichenoid dermatitis with concomitant features of pemphigus foliaceus.
    Fukumoto T; Shiroyama Y; Niizeki H; Kobayashi N; Asada H; Ishii N; Hashimoto T; Miyagawa S
    J Dermatol; 2007 Sep; 34(9):645-9. PubMed ID: 17727368
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Case of bullous pemphigoid coexisting with anti-desmoglein autoantibodies.
    Tie D; Yoshida T; Chinuki Y; Da X; Ishikawa N; Morita E
    J Dermatol; 2017 Jul; 44(7):822-825. PubMed ID: 28342216
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Longitudinal Tracking of Autoantibody Levels in a Pemphigus Vulgaris Patient: Support for a Role of Anti-Desmoglein 1 Autoantibodies as Predictors of Disease Progression.
    Abidi NY; Lainiotis I; Malikowski G; Seiffert-Sinha K; Sinha AA
    J Drugs Dermatol; 2017 Feb; 16(2):135-139. PubMed ID: 28300855
    [TBL] [Abstract][Full Text] [Related]  

  • 38. What are the "true" pathogenic anti-desmoglein antibodies?
    Muro Y; Sugiura K; Akiyama M
    Acta Derm Venereol; 2015 Sep; 95(7):872, 874. PubMed ID: 25881972
    [No Abstract]   [Full Text] [Related]  

  • 39. In vitro pathogenicity assay for anti-desmoglein autoantibodies in pemphigus.
    Ishii K; Amagai M
    Methods Mol Biol; 2013; 961():219-25. PubMed ID: 23325646
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibodies to the amino-terminal domain of desmoglein 1 are retained during transition from pemphigus vulgaris to pemphigus foliaceus.
    España A; Koga H; Suárez-Fernández R; Ohata C; Ishii N; Irarrazaval I; Teye K; Ohyama B; Hashimoto T
    Eur J Dermatol; 2014; 24(2):174-9. PubMed ID: 24776707
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.